www.ccmjournal.org e267 increased procoagulant activity, blunted anticoagulant mechanisms, and suppression of the fibrinolytic system on the other hand, all being part of the host defense mechanism (1, 2) . The interplay between inflammation and blood coagulation is considered to be an essential part of the host defense against infectious agents. The strong proinflammatory response observed during severe sepsis may lead to disseminated intravascular coagulation, which contributes to multiple organ failure and high mortality rates (2) . The protein C (PC) system is an important regulator of hemostasis and the inflammatory response during infection (3, 4) . Initiated by complex formation of thrombin with thrombomodulin, the vitamin K-dependent zymogen PC is converted into its active form, activated protein C (APC). APC serves as one of the main inhibitors of the coagulation system via its capacity to inactivate coagulation factors Va (FVa) and VIIIa (FVIIIa), together with various cofactors including protein S (PS). In addition, APC exerts cytoprotective, anti-inflammatory, and antiapoptotic properties, which are mediated by the protease-activated receptor-1 (PAR1 [3, 4] ). Many studies have shown that low PC and APC levels correlate with the occurrence of organ dysfunction and an adverse outcome in patients with sepsis (3) (4) (5) (6) . Treatment of severe sepsis patients with IV recombinant human APC (rhAPC) was reported to strongly reduce mortality in the Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study published in 2001 (7) ; however, a recently completed confirmatory trial in septic shock patients (PROWESS-SHOCK) did not show any benefit from APC treatment (8) , which led to the withdrawal of this compound from the market (9, 10) .
Melioidosis is an infectious disease caused by the soildwelling bacterium Burkholderia pseudomallei. This potential bioterrorism threat agent is an important cause of community-acquired sepsis in Southeast Asia and Northern Australia with mortalities up to 40% despite appropriate antibiotic therapy (11, 12) . Melioidosis is often associated with pneumonia and bacterial dissemination to distant sites, with many possible disease manifestations, septic shock being the most severe (12) . The high mortality and relatively poor responsiveness of B. pseudomallei to antibiotics emphasize the importance of understanding nonspecific host defense mechanisms.
Our laboratory recently reported pronounced coagulation activation in patients with culture-proven septic melioidosis together with down-regulation of anticoagulant pathways (13, 14) . In particular, levels of PC and PS were markedly decreased, and low levels of PC correlated with a worse clinical outcome (13) , a finding also reported by others (15) . In this study, we investigated the effect of sustained elevated levels of APC during melioidosis, using mice overexpressing human (h) APC (APC high mice [16] ). These transgenic mice express a hyperactivatable form of hAPC (D167F/D172K), which results in a gain in function with respect to APC formation and were especially generated in order to study the role of APC during severe stress (16) . We show that overexpression of APC results in enhanced susceptibility to B. pseudomallei infection as evidenced by a strongly increased mortality, accompanied by increased bacterial loads, elevated levels of proinflammatory cytokines in lungs and plasma, increased histopathology scores, and increased neutrophil influx in the lungs.
MATERIALS AND METHODS

Mice
Pathogen-free 10-week old male wild type (WT) C57BL/6 mice were purchased from Charles River (Maastricht, The Netherlands) and maintained at the animal care facility of the Academic Medical Center (University of Amsterdam), according to national guidelines with free access to food and water. APC high mice on a C57BL/6 genetic background were generated as described (16) and bred in the animal facility of the Academic Medical Center in Amsterdam. All experiments were approved by the Animal Care and Use Committee of the Academic Medical Center.
Experimental Infection and Determination of Bacterial Growth
Experimental melioidosis was induced by intranasal inoculation with B. pseudomallei strain 1026b (300 colony forming units [CFU]/50 µL of 0.9% NaCl) as previously described (17) (18) (19) . For survival experiments, mice (n = 12/group) were checked every 6 hours until death occurred. Sample harvesting and processing and determination of bacterial growth were done as described (17) (18) (19) . For details, see supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/A650).
Assays
Lung homogenates of infected mice were diluted 1:1 in lysis buffer containing 300 mM NaCl, 30 mM Tris, 2 mM MgCl 2 , 2 mM CaCl 2 , 1% Triton X-100 (pH 7.4) and protease inhibitor mix (AEBSF [4-(2-aminoethyl) benzenesulfonfluoride]), EDTA-Na 2 , pepstatin, and leupeptin (all from MP Biomedical, Santa Ana, CA) and were incubated at 4°C for 30 minutes. Homogenates were centrifuged at 1730g at 4°C for 10 minutes. Supernatants were sterilized using 0.22-μm pore-size filters (Millipore, Billerica, MA) and stored at −20°C until analysis. Assays and Western blotting are described in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/ CCM/A650).
Histology and Immunohistology
Paraffin-embedded 4-µm lung sections were stained with hematoxylin and eosin and analyzed for inflammation and tissue damage as described (17) (18) (19) . Details are described in the supplemental data (Supplemental Digital Content 1, http:// links.lww.com/CCM/A650). Granulocyte stainings, using fluorescein isothiocyanate-labeled rat anti-mouse Ly-6G mAb (BD Pharmingen, San Diego, CA) were done as described previously (18, 20) . Slides were counterstained with methylgreen (Sigma-Aldrich, St. Louis, MO). The total tissue area of the Ly-6 stained slides was scanned with a slide scanner (Olympus dotSlide, Tokyo, Japan) and the obtained scans were exported in TIFF format for digital image analysis. The digital images were analyzed with ImageJ (version 2006.02.01, National Institutes of Health, Bethesda, MD), and the immunopositive (Ly6G+) area was expressed as the percentage of the total lung surface area.
Statistical Analysis
Data are expressed as box and whisker plots showing the smallest observation, lower quartile, median, upper quartile, and largest observation or as medians with interquartile ranges (IQRs). All variables were rank transformed prior to analysis. Comparisons between groups were conducted using overall nonparametric analysis of variance with modeled effects for strain, time, and their interaction (if appropriate), followed by post-hoc Mann-Whitney U tests at the individual time points. For survival studies Kaplan-Meier analyses followed by logrank test were performed. All analyses were done using SPSS (SPSS, version 18, Armonk, NY). p values of less than 0.05 were considered statistically significant.
RESuLTS
APC Concentrations in Different Organs of APC high mice
Previous research on the effects of exogenous hAPC during sepsis reported hAPC levels of 44.9 ng/mL in plasma of hAPCtreated patients (21) . To obtain insight in expression of hAPC in different organs in our study, we measured hAPC levels in plasma, lung, kidney, liver, and spleen homogenates of uninfected APC high mice. APC activity was most abundant in lung and spleen homogenates (135 [98.9-165] ng/mL and 108 [70.1-185] ng/mL, respectively; Fig. 1 ). Plasma hAPC levels were 18.1 (14.1-30.7) ng/mL. hAPC levels in WT mice were all below detection limits.
APC high Mice Show an Accelerated Mortality During Experimental Melioidosis
We have previously shown that our model of murine melioidosis is associated with severe sepsis and a high mortality (17) (18) (19) . To investigate whether overexpression of APC impacts on mortality during murine melioidosis, we intranasally infected WT and APC high mice with 300 CFU of B. pseudomallei and observed them during the following 12 days (Fig. 2) . Surprisingly, APC high mice showed a clear survival disadvantage compared with WT mice (p < 0.05). APC high mice started to die shortly beyond 72 hours of infection, eventually showing a mortality of 92% (11 out of 12 mice). In contrast, although the initial mortality occurred simultaneously with that in APC high mice, WT mice demonstrated an eventual mortality of only 50% (6 of 12 mice). These results indicate that overexpression of hAPC is detrimental during experimental melioidosis.
APC Overexpression Facilitates Bacterial Growth and Dissemination
To gain insight into the mechanism underlying the increased mortality of APC high mice, we infected WT and APC high mice with 300 CFU of B. pseudomallei and killed them after 24, 48, or 72 hours to determine bacterial loads in lungs (the primary site of infection), blood, liver, and spleen homogenates (to evaluate the extent of dissemination; Fig. 3 ). Relative to WT mice, APC high mice showed markedly elevated bacterial loads in their lungs (p < 0.001; Fig. 3A ) and at distant body sites 48 hours after infection ( Fig.  3B-D) . Seventy-two hours after infection, APC high mice still showed increased bacterial dissemination compared with WT mice, as reflected by significantly increased bacterial loads in spleen homogenates (p < 0.05; Fig. 3D ). At this time point, bacterial loads in lungs were modestly but significantly lower in APC high mice compared with WT mice (p < 0.05; Fig. 3A ). These data indicate that overexpression of APC facilitates the early growth and dissemination of B. pseudomallei during pneumonia-derived sepsis. . Activated protein C (APC) high mice show an accelerated mortality during experimental melioidosis. Wild type (WT) and APC high mice were infected intranasally with 300 CFU of Burkholderia pseudomallei and mortality was assessed every 6 hr, n = 12 mice per group. Comparison between groups was done by using Kaplan-Meier analysis followed by log-rank tests.
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Our model of melioidosis is associated with profound lung pathology (17, 18) . Both WT and APC high mice infected with B. pseudomallei showed inflammatory infiltrates in the lungs characterized by interstitial inflammation together with necrosis, endothelialitis, bronchitis, edema, thrombi, and pleuritis ( Fig. 4A-C) . APC overexpression leads to considerably lung pathology during infection as is reflected in significantly higher lung histology scores in APC high mice compared with WT mice 48 hours after infection (p < 0.05; Fig. 4A -C). Neutrophils have shown to play a major role in the host defense against B. pseudomallei (17, 18, 22) . In order to investigate the role of neutrophils in our model, we measured percentage of Ly-6G staining in infected lung tissue ( Fig. 4D-F) . Fourty-eight hours after infection, APC high mice displayed significantly increased neutrophil numbers in their lungs compared with WT mice (p < 0.05; Fig. 4D-F) . These data were confirmed by the higher amounts of myeloperoxidase, a marker for total neutrophil content, in lung homogenates of APC high mice compared with WT mice 48 hours after inoculation ( Fig. 4G) . No differences in total cell counts in bronchoalveolar lavage fluid (BALF) were seen between WT and APC high mice at any of the time points ( Fig. 4H) . However, in APC high mice, BALF contained more neutrophils after 48 hours compared with WT mice (p < 0.01; Fig. 4I ). Together, these data show a more severe proinflammatory response in the lungs of APC high mice accompanied by increased recruitment of neutrophils.
APC high Mice Demonstrate an Enhanced Cytokine Response After Infection With B. pseudomallei
Because cytokines are important regulators of the host immune response during melioidosis (12), we measured pulmonary and plasma levels of tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), IL-10, IL-12p70, interferon-γ (INFγ), monocyte chemotactic protein-1 (MCP-1), and keratinocyte-derived chemokine (KC) ( Table 1) . The lung and plasma levels of these mediators did not differ between mouse strains at 24 or 72 hours after infection. At 48 hours, when APC high mice displayed higher bacterial burdens in various body sites, these genetically modified animals showed higher concentrations of IL-6, MCP-1, and KC in lungs and higher levels of TNF-α, IL-6, IL-12p70, INF-γ, and MCP-1 in plasma compared with WT mice.
Overexpression of APC Leads to Decreased Coagulation Activation, Only at Late Time Points
Having established that overexpression of APC plays a detrimental role during infection with B. pseudomallei, we next wondered whether this would impact activation of coagulation in the lungs and systemically during infection. Therefore, thrombinantithrombin complexes (TATc) levels, a parameter of coagulation induction, were measured in lung homogenates, BALF and plasma of WT and APC high mice 24, 48, and 72 hours after inoculation with B. pseudomallei. Interestingly, at 48 hours, when marked differences in CFU counts and neutrophil influx were seen between WT and APC high mice, no differences in TATc levels were observed in either the pulmonary or the systemic compartment ( Fig. 5A-C) . Seventy-two hours after infection, however, pulmonary TATc levels were significantly decreased in APC high mice compared with WT mice (p < 0.05 and p < 0.01 for lung homogenates and BALF, respectively). To analyze whether overexpression of APC leads to changes in other anticoagulant factors, we measured plasma levels of antithrombin (AT), one of the most potent antioagulants. No significant differences could be detected between WT and APC high mice at any of the time points, indicating that the observed decrease in TATc is most likely attributable to overexpression of APC (i.e., not by changes in AT levels) ( Fig. 5D) . Finally, we performed Western blots on fibrin and fibrin degradation products in lung homogenates 72 hours after infection, which revealed strongly reduced amounts of fragment X and D-dimer in APC high mice (fragment X: 97% vs 22%, p < 0.05; D-dimer: 116% vs 36%, p < 0.01) ( Fig. 5E-G) . Taken together, the observed impairment in host defense mechanisms during severe experimental Gram-negative sepsis as a result of enhanced APC expression concurs during decreased coagulation activation.
DISCuSSION
During severe pneumosepsis, a shift toward increased procoagulant activity and inhibition of anticoagulant activity and fibrinolysis occurs, changes that are thought to contain the infection and thereby protect the host against the detrimental effects of the infection (1, 2) . APC is a pleiotropic protease with anticoagulant, profibrinolytic, and anti-inflammatory properties (3, 4) . Many clinical studies have shown reduced plasma PC activity in patients with severe sepsis, which was associated with organ dysfunction and early death (5, 6, 23, 24) . Also in patients with B. pseudomallei-induced pneumosepsis, low levels of PC and of its cofactor protein S were found (13, 15) . These data paved way for administration of APC as an additional treatment in pneumosepsis patients, and many preclinical and clinical studies have demonstrated its protective effects (7, 25) . However, due to a significant lack of benefit in sepsis patients in the recent PROWESS-SHOCK trial, rhAPC was recently withdrawn from the market (9, 10) . Despite this announcement, several preclinical and clinical studies provided insight into the mechanisms of action of rhAPC administration in models of endotoxemia and sepsis. These studies have shown that systemic administration of rhAPC inhibits systemic and intrabronchial coagulopathy and inflammation (4, www.ccmjournal.org e271 7, 25). More specifically, IV administration of rhAPC was able to reduce local, intrapulmonal, coagulation, and inflammation in lipopolysaccharide (LPS)-induced lung inflammation in healthy volunteers (26, 27) and intrapulmonal coagulation in rodent models of bacterial pneumonia (28, 29) . Melioidosis is often associated with severe pneumosepsis (11, 12) , but data about effects of APC during this disease are limited to a single case report (30) . Therefore, in this study, we now tried to determine whether APC would be protective during melioidosis by comparing mice expressing high levels of hAPC with WT mice. Our data show, surprisingly, that elevated concentrations of hAPC resulted in a survival disadvantage, accompanied by significantly increased pulmonary and systemic bacterial growth. Furthermore, APC high mice had increased pulmonary histopathology, increased influx of neutrophils, and increased release of proinflammatory cytokines in their lungs and blood. Only at later stages of infection, coagulation activation was blunted in APC high mice. These data indicate that, in contrast to our hypothesis, overexpression of APC has a detrimental effect during severe pneumosepsis (melioidosis) caused by B. pseudomallei.
To answer our research question, we used mice expressing a hyperactivatable form of human APC, which is efficiently activated by mouse thrombin both in the absence and presence of mouse thrombomodulin (16) . Before their use in the experiments, all mice were checked for transgene expression by PCR. Although one could argue that it would have been better to use mice overexpressing murine APC instead of human APC, it is less likely that such mice would yield significantly different results since both rhAPC (28, 29, 31) and recombinant murine APC (rmAPC [32, 33] ) have shown (protective) effects in murine models of LPS-induced endotoxemia (31), LPS-induced lung injury (32), ventilator-induced lung injury (33) , and pneumococcal pneumonia (28, 29) . Of note, although APC high mice respond to thrombin with increased APC production, our results cannot be extrapolated to mice with enhanced levels of the zymogen protein C. Our results are in contrast with previous data in murine models of pneumosepsis and endotoxin-induced lung inflammation. IV APC prevented LPS-induced pulmonary vascular injury by inhibiting accumulation of leukocytes (34) and cytokine production (35) in rats. Furthermore, inhalation of APC inhibited LPS-induced pulmonary inflammation in mice (32) . In a model of murine pneumococcal pneumonia, IV administration of rmAPC attenuated coagulopathy and improved survival (28) and administration of rmAPC reduced inflammation when administered early in the same model (29) . However, not all experimental models showed clear antiinflammatory effects of APC during infection. In a model of Pseudomonas aeruginosa pneumonia in rats, IV rhAPC inhibited local and systemic coagulation but did not show any protective effects on host defense (36) . Furthermore, during P. aeruginosa-induced acute lung injury, IV rhAPC worsened oxygenation impairment and induced an increase in extracellular lung water, in lung inflammatory cell recruitment, and in systemic and bronchoalveolar levels of the proinflammatory cytokines TNF-α and IL-6 (37). The latter results seem to be more in line with our data, as we also demonstrated that APC induced an increased pulmonary neutrophil influx together with increased levels of proinflammatory cytokines.
One of the main properties of APC is its anticoagulant function via inhibition of FVa and FVIIIa (3, 4) . Indeed, after 72 hours of infection decreased coagulation activation, as reflected by lower levels of TATc and fibrin degradation products, including fragment X and D-dimer, were measured in lung homogenates and BALF of APC high mice. Clearly, APC overexpression did not lead to a compensatory decrease in AT levels, indicating that the low TATc levels are most likely attributable to the anticoagulant effects of APC overexpression. These data are in line with previous data of experimental models of pneumosepsis showing that IV administration of APC blunted coagulopathy (28, 29, 36) . Recent data from our laboratory showed that interference with fibrin deposition impacts the outcome of experimental melioidosis (18, 19) . More specifically, mice deficient for plasminogen activator type 1, which are expected to have decreased fibrin depositions, showed increased bacterial growth in this model (18) , whereas tissuetype plasminogen activator-deficient mice, which are expected to display enhanced fibrin depositions, demonstrated reduced bacterial growth and dissemination in this same model (19) . Together, these data suggest that reduced coagulation in APC high mice may have contributed to impaired defense against bacterial growth and dissemination. At present, it remains to be elucidated why coagulation was not inhibited in APC high mice early after instillation of B. pseudomallei, although clearly the extent of coagulation activation was relatively limited before 72 hours of infection. Interestingly, recent data showed that APC also might have procoagulant properties (38) . APC is able to shed Kunitz domain 1 from membrane-bound tissue factor pathway inhibitor, leading to up-regulation of tissue factor thereby initiating FXa-dependent coagulation (38) . The procoagulant properties of APC might have, although speculative, counteracted the anticoagulant influences of high APC levels during the early phase of infection.
Besides its effects on coagulation, APC is also known as a protein with anti-inflammatory and cytoprotective properties. On the one hand, these effects can be mediated via binding of APC to the endothelial PC receptor (EPCR) and subsequent signaling via PAR1. Activation of the APC-EPCR-PAR1 axis may result in anti-inflammatory and antiapoptotic activities, as well as stabilization and thereby protection of the endothelial barrier (4) . Indeed, in a model of diabetic nephropathy, overexpression of APC was protective via inhibition of endothelial and podocyte apoptosis (16) . On the other hand, the protective effects of APC can be mediated via EPCR independent, CD11b/ CD18-PAR1-dependent mechanisms (39) (40) (41) or induced via direct binding of APC to activated α 3 β 1 , α 5 β 1 , and α V β 3 integrins. This interaction proved to be essential for inhibition of neutrophil extravasation into the bronchoalveolar space of mice induced by rAPC (42) . Our data show that overexpression of APC, which theoretically may have led to anti-inflammatory effects, was not protective in our model. In contrast, overexpression of APC was associated with a strong proinflammatory phenotype, as reflected by enhanced neutrophil influx, increased cytokine production, and worse histopathology, particularly at 48 hours after infection. These data contrast with previous findings from our laboratory showing reduced proinflammatory cytokine levels in mice treated with APC shortly after infection with Streptococcus pneumoniae via the airways (29) . As such, we expected APC high mice to display an attenuated early inflammatory response in the lung after infection with B. pseudomallei. In light of the importance for a swift induction of an adequate innate immune response for protective immunity (11, 12) , this could have explained the observed enhanced bacterial growth and dissemination at 48 hours. However, with the readouts used here, anti-inflammatory effects could not be detected in APC high mice, leaving the mechanism by which sustained elevation of APC levels disturb host defense mechanisms open for speculation. Nonetheless, our results clearly demonstrate that high APC levels do not prevent excessive inflammation or death. The increased inflammatory response in APC high mice likely was the consequence of the higher bacterial loads, providing a stronger proinflammatory stimulus, which could not be controlled by high APC concentrations. This likely also applies to the increased neutrophil numbers in lungs at 48 hours after infection. Although neutrophils are critical players in the host defense against B. pseudomallei (22) , previous studies have shown an association between overwhelming neutrophil recruitment and increased mortality during experimental melioidosis (17, 18) . These observations can be explained by the fact that neutrophil activation might acts as a "double-edged sword," on the one hand aiding in the antibacterial response by attacking bacteria and facilitating their killing, whereas on the other hand causing collateral tissue damage.
In this study, we used mice overexpressing hAPC, which represents a different approach to study the effect of APC than adopted in previous studies using exogenous administration of APC via the IV or intraperitoneal route or via inhalation. The advantage of our model is that high levels of APC were present during the whole experiment, whereas in models of repeated exogenous administration levels of APC vary over time due to the short half-life of APC in the circulation. By measuring hAPC levels in various organs, we showed that APC is overexpressed in APC high mice throughout the body, which is in accordance with previous studies in which these mice were used (16) . Furthermore , the APC levels found in our study almost paralleled those measured in the PROWESS trial (45 ng/mL), in which patients were treated with continuous IV administration of rhAPC (21) . Of note, as to mimic the human situation as much as possible, we considered continuous administration of APC in mice via the IV route. However, this is hard to achieve in freely moving mice. On the other hand, a limitation of our study is that it might be a challenge to extrapolate our results obtained in genetically modified mice to the human situation. Furthermore, one could argue that the observed results are only applicable to this particular model. The recent failure of the PROWESS-SHOCK trial, in which humans with septic shock received rhAPC (8) , might be related to the fact that in this study a very heterogeneous sepsis patient population was studied with a relatively low overall mortality.
CONCLuSION
This study is the first to report on the role of overexpression of endogenous APC in melioidosis. Our data clearly show that sustained elevated levels of APC impair host defense during severe experimental Gram-negative sepsis caused by B. pseudomallei (melioidosis), as reflected by increased bacterial growth and dissemination, increased pulmonary neutrophil influx, increased cytokine production, and early death.
